Journal of Dental School

1. Stenman G, Magnusson B, Lennartsson B, Juberg‐Ode M. In vitro growth characteristics of human odontogenic keratocysts and dentigerous cysts. J Oral Pathol. 1986;15(3):143-5. doi: 10.1111/j.1600-0714.1986.tb00595.x

2. Hume W, Moore J, Main D. Differences inin vitro growth of epithelium from inflammatory and developmental odontogenic cysts. Br J Oral Maxillofac Surg. 1990;28(2):85-8. doi: 10.1016/0266-4356(90)90127

3. Singh HP, Chahal GK, Sharma G, Gandhi P. A systematic review on odontogenic cysts and tumours. J Oral Maxillofac Pathol. 2024;28(2):268-74. doi: 10.4103/jomfp.jomfp_460_23

4. Sulistyani LD, Iskandar L, Zairinal VN, Arlen AK, Purba F, Ariawan D. Transformation of Odontogenic Cysts to Neoplasms - A Systematic Review. Ann Maxillofac Surg. 2023 Jan-Jun;13(1):76-80. doi: 10.4103/ams.ams_226_22

5. Waldron CA, Mustoe TA. Primary intraosseous carcinoma of the mandible with probable origin in an odontogenic cyst. Oral surgery, oral medicine, oral pathology. 1989;67(6):716-24. doi: 10.1016/0030-4220(89)90014-5

6. Johnson LM, Sapp JP, McIntire DN. Squamous cell carcinoma arising in a dentigerous cyst. J Oral Maxillofac Surg. 1994;52(9):987-90. doi: 10.1016/s0278-2391(10)80087-4

7. Eversole L, Sabes W, Rovin S. Aggressive growth and neoplastic potential of odontogenic cysts. With special reference to central epidermoid and mucoepidermoid carcinomas. Cancer. 1975;35(1):270-82. doi: 10.1002/1097-0142(197501)35:1<270::aid-cncr2820350134>3.0.co;2-y

8. Manganaro AM, Cross SE, Startzell JM. Carcinoma arising in a dentigerous cyst with neck metastasis. Head Neck. 1997;19(5):436-9. doi: 10.1002/(sici)1097-0347(199708)19:5<436::aid-hed12>3.0.co;2-5

9. Manor E, Kachko L, Puterman MB, Szabo G, Bodner L. Cystic lesions of the jaws-a clinicopathological study of 322 cases and review of the literature. Int J Med Sci. 2012;9(1):20-6. doi: 10.7150/ijms.9.20

10. Yeo JF, Zain RB, Ti LS, Zhao YY, Ngeow WC. Clinicopathological study of dentigerous cysts in Singapore and Malaysia. Malays J Pathol. 2007;29(1):41-7.

11. Gao L, Li T. In vitro study on bone resorption of odontogenic cysts and ameloblastomas. Zhonghua Kou Qiang Yi Xue Za Zhi. 2005;40(3):233-6.

12. Sun CX, Ririe C, Henkin JM. Hyperplastic dental follicle-review of literature and report of two cases in one family. Chin J Dent Res. 2010;13(1):71-5.

13. Hunter KD, Speight PM. The diagnostic usefulness of immunohistochemistry for odontogenic lesions. Head Neck Pathol. 2014;8(4):392-9. doi: 10.1007/s12105-014-0582-0

14. Mashhadiabbas F, Gholami S, Chafjiri MM. Central Maxillary Mucoepidermoid Carcinoma: A Case Report. J Dent Sch. 2024;42(1):45-8. doi: 10.22037/jds.v42i1.44905

15. Barnes L, Eveson J, Reichart P, Sidransky D. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. 2005. Chap: 6, P:306-7.

16. Bhargava D, Moturi K. Odontogenic Keratocyst (OKC): Reverting Back from Tumour (WHO 2005) to Cyst (WHO 2017). J Maxillofac Oral Surg. 2024;23(2):340-1. doi: 10.1007/s12663-023-02009-z

17. Bhargava D, Deshpande A, Pogrel MA. Keratocystic odontogenic tumour (KCOT)—a cyst to a tumour. Oral Maxillofac Surg. 2012;16(2):163-70. doi: 10.1007/s10006-011-0302-9

18. Ogden G, Chisholm D, Kiddie R, Lane D. p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol. 1992;45(11):1007-10. doi: 10.1136/jcp.45.11.1007

19. Sharif FN, Oliver R, Sweet C, Sharif MO. Interventions for the treatment of keratocystic odontogenic tumours. Cochrane Database Syst Rev. 2015;2015(11):CD008464

20. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65(23):10946-51. doi: 10.1158/0008-5472.CAN-05-2018

21. Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int. 2007;6(1):92-7.

22. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-10. doi: 10.1038/nature05372

23. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006;351(4):820-4. doi: 10.1016/j.bbrc.2006.10.128

24. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-8.

25. Sathi GA, Tamamura R, Tsujigiwa H, Katase N, Lefeuvre M, Siar CH, et al. Analysis of immunoexpression of common cancer stem cell markers in ameloblastoma. Exp Ther Med. 2012;3(3):397-402. doi: 10.3892/etm.2011.437

26. Atarbashi Moghadam S, Atarbashi Moghadam F, Mokhtari S, Eini E. Immunohistochemical analysis of P63 expression in odontogenic lesions. Biomed Res Int. 2013:2013:624176. doi: 10.1155/2013/624176

27. Huang J, Zhang D, Xie F, Lin D. The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study. J Vet Sci. 2015;16(2):225-31. doi: 10.4142/jvs.2015.16.2.225

28. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93(5):705-16. doi: 10.1016/s0092-8674(00)81433-6

29. Mohan S, Epstein JB. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol. 2003;39(6):537-46. doi: 10.1016/s1368-8375(03)00035-6

30. Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res. 2002;62(22):6706-11.

31. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998;58(2):362-6.

32. Wang J, Zhang X, Ding X, Xing S, Li H, Zhang W, et al. Cyclooxygenase‑2 expression in keratocystic odontogenic tumour decreased following decompression.Mol Clin Oncol. 2013;1(6):982-6. doi: 10.3892/mco.2013.169

33. Mendes RA, Carvalho JF, van der Waal I. Potential relevance of cyclooxygenase‐2 expression in keratocystic odontogenic tumours–an immunohistochemical study. J Oral Pathol Med. 2011;40(6):497-503. doi: 10.1111/j.1600-0714.2010.00997.x

34. Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.

Cell Stem Cell. 2013;12(1):15-30. doi: 10.1016/j.stem.2012.12.007

35. Juuri E. Sox2+ stem and progenitor cells in tooth renewal and odontogenic tumors. 2014. http://hdl.handle.net/10138/45069

36. Neradil J, Veselska R. Nestin as a marker of cancer stem cells. Cancer Sci. 2015;106(7):803-11. doi: 10.1111/cas.12691

37. Chiou S-H, Yu C-C, Huang C-Y, Lin S-C, Liu C-J, Tsai T-H, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14(13):4085-95. doi: 10.1158/1078-0432.CCR-07-4404.

38. Özçamur-güneş Ç, Olgaç V, Soluk-tekkeşın M, Köseoğlu B. KI-67 and cyclooxygenase-2 expressions in odontogenic keratocysts, dental follicle and ameloblastoma-an immunohistochemical study. JIUFD 2014;48(3):37-51. doi: 10.17096/JIUFD.12386

39. Strojnik T, Røsland GV, Sakariassen PO, Kavalar R, Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol. 2007;68(2):133-43; discussion 143-4. doi: 10.1016/j.surneu.2006.10.050

40. Seyedmajidi M, Shafaee S, Siadati S, Moghaddam EA, Ghasemi N, Bijani A, Najafi M. Immunohistochemical analysis of COX-2 expression in dentigerous cyst, keratocystic odontogenic tumor and ameloblastoma: A comparative study. Dent Res J (Isfahan). 2015;12(3):278-84.

41. Lei Y, Jaradat JM, Owosho A, Adebiyi KE, Lybrand KS, Neville BW, et al. Evaluation of SOX2 as a potential marker for ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(5):608-16.e1. doi: 10.1016/j.oooo.2014.01.017

42. Farshbaf A, Zare R, Mohajertehran F, Mohtasham N. New diagnostic molecular markers and biomarkers in odontogenic tumors. Mol Biol Rep. 2021;48(4):3617-28. doi: 10.1007/s11033-021-06286-0

43. Almeida LE, Lloyd D, Boettcher D, Kraft O, Zammuto S. Immunohistochemical Analysis of Dentigerous Cysts and Odontogenic Keratocysts Associated with Impacted Third Molars—A Systematic Review. Diagnostics (Basel). 2024;14(12):1246. doi: 10.3390/diagnostics14121246

44. Oginni FO, Alasseri N, Ogundana OM, Famurewa BA, Pogrel A, Al-Moraissi EA. An evidence-based surgical algorithm for management of odontogenic keratocyst. Oral Maxillofac Surg. 2023;27(2):201-12. doi: 10.1007/s10006-022-01064-z

45. Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol. 2002;38(3):219-26. doi: 10.1016/s1368-8375(01)00065-3

46. Gadbail AR, Hande A, Chaudhary M, Nikam A, Gawande M, Patil S, et al. Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD‐105 antigen. J Oral Pathol Med. 2011;40(3):263-9. doi: 10.1111/j.1600-0714.2010.00962.x

47. Henriques ÁCG, Vasconcelos MG, Galvão HC, de Souza LB, de Almeida Freitas R. Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):468-75.

doi: 10.1016/j.tripleo.2011.05.033

48. Prescott SM, Fitzpatrick F. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta. 2000;1470(2):M69-78.

doi: 10.1016/s0304-419x(00)00006-8

49. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K, Ito H. Cyclo-oxygenase-1 and-2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol. 2005;41(3):304-12.

doi: 10.1016/j.oraloncology.2004.09.009

50. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 1999;59(5):991-4.

51. Gallo O, Masini E, Bianchi B, Bruschini L, Paglierani M, Franchi A. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol. 2002;33(7):708-14. doi: 10.1053/hupa.2002.125376

52. Ristimäki A, editor Cyclooxygenase 2: from inflammation to carcinogenesis. Cancer and Inflammation: Novartis Foundation Symposium 256; 2004: Wiley Online Library.doi.org/10.1002/0470856734

53. Mendes RA, Carvalho JF, van der Waal I. An overview on the expression of cyclooxygenase-2 in tumors of the head and neck. Oral Oncol. 2009;45(10):e124-8. doi: 10.1016/j.oraloncology.2009.03.016

54. Finkelstein MW, Hellstein JW, Lake KS, Vincent SD. Keratocystic odontogenic tumor: a retrospective analysis of genetic, immunohistochemical and therapeutic features. Proposal of a multicenter clinical survey tool. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(1):75-83. doi: 10.1016/j.oooo.2013.03.018

55. Mendes RA, Carvalho JF, van der Waal I. A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(3):333-9. doi: 10.1016/j.tripleo.2010.10.004

56. Zimmermann KC, Sarbia M, Weber A-A, Borchard F, Gabbert HE, Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 1999;59(1):198-204.

57. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y, et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res. 2000;6(4):1229-38.

58. Ogata S, Kubota Y, Yamashiro T, Takeuchi H, Ninomiya T, Suyama Y, Shirasuna K. Signaling pathways regulating IL-1α-induced COX-2 expression. J Dent Res. 2007;86(2):186-91.

doi: 10.1177/154405910708600215

59. Suyama Y, Kubota Y, Ninomiya T, Shirasuna K. Immunohistochemical analysis of interleukin‐1α, its type I receptor and antagonist in keratocystic odontogenic tumors. J Oral Pathol Med. 2008;37(9):560-4. doi: 10.1111/j.1600-0714.2008.00667.x

60. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 2000;105(11):1589-94. doi: 10.1172/JCI9621

61. Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol. 2000;164(1):361-70. doi: 10.4049/jimmunol.164.1.361

62. Zhang L, Sun Z, Chen X, Chen Z. Immunohistochemical expression of SHH, PTC, SMO and GLI1 in glandular odontogenic cysts and dentigerous cysts. Oral Dis. 2010; 16(8):818-22. doi: 10.1111/j.1601-0825.2010.01697.x

63. Kumamoto H, Ohki K, Ooya K. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas.

J Oral Pathol Med. 2004;33(3):185-90. doi: 10.1111/j.0904-2512.2004.00070.x

64. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, et al. P53‐mediated induction of Cox‐2 counteracts p53‐or genotoxic stress‐induced apoptosis. EMBO J. 2002;21(21):5635-44. doi: 10.1093/emboj/cdf591

65. Harris M. Odontogenic cyst growth and prostaglandin-induced bone resorption. Ann R Coll Surg Engl.. 1978;60(2):85.

66. Fracon RN, Teófilo JM, Satin RB, Lamano T. Prostaglandins and bone: potential risks and benefits related to the use of nonsteroidal anti-inflammatory drugs in clinical dentistry. J Oral Sci. 2008;50(3):247-52. doi: 10.2334/josnusd.50.247

67. Driemel O, Rieder J, Morsczeck C, Schwarz S, Hakim SG, Müller-Richter U, et al. Comparison of clinical immunohistochemical findings in keratocystic odontogenic tumours and ameloblastomas considering their risk of recurrence. Mund Kiefer Gesichtschir. 2007;11(4):221-31. doi: 10.1007/s10006-007-0068-2

68. Banerjee A, Kamath VV, Sundaram L, Krishnamurthy SS. OCT4 and SOX2 are reliable markers in detecting stem cells in odontogenic lesions. J Orofac Sci.. 2016;8(1):16-21. doi:10.4103/0975-8844.181920

69. Weina K, Utikal J. SOX2 and cancer: current research and its implications in the clinic.Clin Transl Med. 2014:3:19. doi: 10.1186/2001-1326-3-19

70. Baher MK, Moscowchi A, Atarbashi-Moghadam S. Prevalence of oral HPV in healthy and lesion-bearing populations in Iran: a systematic review and meta-analysis. BMC Oral Health. 2025;25(1):699. doi: 10.1186/s12903-025-06085-0

71. Martínez-Ramírez I, Del-Castillo-Falconi V, Mitre-Aguilar IB, Amador-Molina A, Carrillo-García A, Langley E, et al. SOX2 as a New Regulator of HPV16 Transcription. Viruses. 2017;9(7). doi: 10.3390/v9070175

72. Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX 2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013;121(6):509-16. doi: 10.1111/eos.12095

73. Heikinheimo K, Kurppa K, Laiho A, Peltonen S, Berdal A, Bouattour Aa, et al. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res. 2015;94(1):101-11. doi: 10.1177/0022034514556815

74. Qiao B, He B, Cai J, Yang W. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol.. 2014;7(1):28-37.

75. Shear M, Speight PM. Cysts of the oral and maxillofacial regions: John Wiley & Sons; 2008. Chap 3, P: 56-8.

76. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60(4):585-95. doi: 10.1016/0092-8674(90)90662-x

77. Kachinsky AM, Dominov JA, Miller JB. Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. J Histochem Cytochem. 1995;43(8):843-7. doi: 10.1177/43.8.7542682

78. Fröjdman K, Pelliniemi L, Lendahl U, Virtanen I, Eriksson J. The intermediate filament protein nestin occurs transiently in differentiating testis of rat and mouse. Differentiation. 1997;61(4):243-9. doi: 10.1046/j.1432-0436.1997.6140243.x

79. Holmin S, Almqvist P, Lendahl U, Mathiesen T. Adult nestin‐expressing subependymal cells differentiate to astrocytes in response to brain injury. Eur J Neurosci. 1997;9(1):65-75. doi: 10.1111/j.1460-9568.1997.tb01354.x

80. Frisén J, Johansson CB, Török C, Risling M, Lendahl U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol. 1995;131(2):453-64. doi: 10.1083/jcb.131.2.453

81. Abdel‐Rahman A, Rao MS, Shetty AK. Nestin expression in hippocampal astrocytes after injury depends on the age of the hippocampus. Glia. 2004;47(4):299-313. doi: 10.1002/glia.20047

82. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 1992;52(19):5334-41.

83. Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad Ø. Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res. 1994;54(2):354-6.

84. Tohyama T, Lee V-Y, Rorke L, Marvin M, McKay R, Trojanowski J. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest.. 1992;66(3):303-13.

85. Sharpe PT. Neural crest and tooth morphogenesis. Adv Dent Res. 2001:15:4-7. doi: 10.1177/08959374010150011001

86. Ruch JV, Lesot H, Bege-Kirn C. Odontoblast differentiation. Int J Dev Biol. 1995;39(1):51-68.

87. Slavkin HC, MacDougall M, Zeichner‐David M, Oliver P, Nakamura M, Snead ML, et al. Molecular determinants of cranial neural crest‐derived odontogenic ectomesenchyme during dentinogenesis. Am J Med Genet Suppl. 1988:4:7-22. doi: 10.1002/ajmg.1320310508

88. McLachlan JL, Smith AJ, Sloan AJ, Cooper PR. Gene expression analysis in cells of the dentine–pulp complex in healthy and carious teeth. Arch Oral Biol. 2003;48(4):273-83. doi: 10.1016/s0003-9969(03)00003-7

89. About I, Mitsiadis TA. Molecular aspects of tooth pathogenesis and repair: in vivo and in vitro models. Adv Dent Res. 2001:15:59-62. doi: 10.1177/08959374010150011501

90. Fujita S, Hideshima K, Ikeda T. Nestin expression in odontoblasts and odontogenic ectomesenchymal tissue of odontogenic tumours. J Clin Pathol. 2006;59(3):240-5. doi: 10.1136/jcp.2004.025403